Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Survey of the effects of a column for adsorption of β2-microglobulin in patients with dialysis-related amyloidosis in Japan.

Gejyo F, Amano I, Ando T, Ishida M, Obayashi S, Ogawa H, Ono T, Kanno Y, Kitaoka T, Kukita K, Kurihara S, Sato M, Shin J, Suzuki M, Takahashi S, Taguma Y, Takemoto Y, Nakazawa R, Nakanishi T, Nakamura H, Hara S, Hiramatsu M, Furuya R, Masakane I, Tsuchida K, Motomiya Y, Morita H, Yamagata K, Yoshiya K, Yamakawa T; Society of β2-Microglobulin Adsorption Therapy.

Ther Apher Dial. 2013 Feb;17(1):40-7. doi: 10.1111/j.1744-9987.2012.01130.x. Epub 2012 Nov 20.

PMID:
23379492
2.

Beta2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis.

Suzuki K, Shimazaki M, Kutsuki H.

Ther Apher Dial. 2003 Feb;7(1):104-7. Review.

PMID:
12921124
3.

Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.

Gejyo F, Kawaguchi Y, Hara S, Nakazawa R, Azuma N, Ogawa H, Koda Y, Suzuki M, Kaneda H, Kishimoto H, Oda M, Ei K, Miyazaki R, Maruyama H, Arakawa M, Hara M.

Artif Organs. 2004 Apr;28(4):371-80.

PMID:
15084199
4.

Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.

Yamamoto Y, Hirawa N, Yamaguchi S, Ogawa N, Takeda H, Shibuya K, Kawahara K, Kojima H, Dobashi Y, Fujita M, Azusima K, Miyazaki N, Kobayashi M, Kobayashi C, Fujiwara A, Yuto J, Saka S, Yatsu K, Toya Y, Yasuda G, Ohnishi T, Umemura S.

Ther Apher Dial. 2011 Oct;15(5):466-74. doi: 10.1111/j.1744-9987.2011.00937.x. Epub 2011 May 25.

PMID:
21974700
5.

New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion.

Furuyoshi S, Nakatani M, Taman J, Kutsuki H, Takata S, Tani N.

Ther Apher. 1998 Feb;2(1):13-7. Review.

PMID:
10227783
6.

beta(2)-Microglobulin-selective direct hemoperfusion column for the treatment of dialysis-related amyloidosis.

Kutsuki H.

Biochim Biophys Acta. 2005 Nov 10;1753(1):141-5. Epub 2005 Sep 6. Review.

PMID:
16168723
7.

Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.

Abe T, Uchita K, Orita H, Kamimura M, Oda M, Hasegawa H, Kobata H, Fukunishi M, Shimazaki M, Abe T, Akizawa T, Ahmad S.

Kidney Int. 2003 Oct;64(4):1522-8.

8.

Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis.

Hiyama E, Hyodo T, Kondo M, Otsuka K, Honma T, Taira T, Yoshida K, Uchida T, Endo T, Sakai T, Baba S, Hidai H.

Nephron. 2002 Oct;92(2):501-2. No abstract available.

PMID:
12218344
9.

[Diagnostic and therapeutic aspects of dialysis-related amyloidosis].

Kopeć J.

Przegl Lek. 2006;63(7):567-72. Review. Polish.

PMID:
17203811
10.

Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis.

Gejyo F, Teramura T, Ei I, Arakawa M, Nakazawa R, Azuma N, Suzuki M, Furuyoshi S, Nankou T, Takata S, et al.

Artif Organs. 1995 Dec;19(12):1222-6.

PMID:
8967878
11.

Effectiveness of β(2)-microglobulin adsorption column in treating dialysis-related amyloidosis: a multicenter study.

Kuragano T, Inoue T, Yoh K, Shin J, Fujita Y, Yoshiya K, Kim JI, Sakai R, Sekita K, Goto T, Fukagawa M, Nakanishi T.

Blood Purif. 2011;32(4):317-22. doi: 10.1159/000330332. Epub 2011 Sep 16.

PMID:
21934303
12.

A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column.

Gejyo F, Homma N, Hasegawa S, Arakawa M.

Artif Organs. 1993 Apr;17(4):240-3.

PMID:
8498903
13.

[Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].

Higuchi N, Maruyama H.

Clin Calcium. 2004 May;14(5):744-9. Review. Japanese.

PMID:
15577036
14.

A new treatment for dialysis-related amyloidosis with beta 2-microglobulin adsorbent column.

Nakazawa R, Azuma N, Suzuki M, Nakatani M, Nankou T, Furuyoshi S, Yasuda A, Takata S, Tani N, Kobayashi F.

Int J Artif Organs. 1993 Dec;16(12):823-9.

PMID:
8175198
15.

Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.

Gejyo F, Homma N, Arakawa M.

Kidney Int Suppl. 1993 Jun;41:S78-82. Review.

PMID:
8320951
16.

Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.

Saito A, Gejyo F.

Ther Apher Dial. 2006 Aug;10(4):316-20.

PMID:
16911183
17.

Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.

Jimenez RE, Price DA, Pinkus GS, Owen WF Jr, Lazarus JM, Kay J, Turner JR.

Am J Surg Pathol. 1998 Jun;22(6):729-35.

PMID:
9630180
18.

Direct hemoperfusion with a beta2-microglobulin-selective adsorbent column eliminates inflammatory cytokines and improves pulmonary oxygenation.

Kono K, Toda S, Hora K, Kiyosawa K.

Ther Apher Dial. 2009 Feb;13(1):27-33. doi: 10.1111/j.1744-9987.2009.00652.x.

PMID:
19379167
19.
20.

New type of amyloidosis. a). beta 2-Microglobulin and hemodialysis.

Gejyo F, Arakawa M.

Intern Med. 1993 Dec;32(12):925-7. No abstract available.

Supplemental Content

Support Center